AstraZeneca PLC (BUE:AZN)
ARS 42025 -50 (-0.12%) Market Cap: 219.46 Tn Enterprise Value: 245.64 Tn PE Ratio: 33.69 PB Ratio: 5.51 GF Score: 64/100

AstraZeneca PLC Investor science conference call: ASCO GI 2022 Transcript

Jan 24, 2022 / 07:00PM GMT
Release Date Price: ARS214.5
Operator

Welcome, ladies and gentlemen, to AstraZeneca's investor conference call, ASCO GI 2022. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.

The company intends to utilize the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca. Although we believe our expectations are based on reasonable assumptions, by their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements made on this call reflect the knowledge and information available at the time of this call. The company undertakes no obligation to update forward-looking statements. Please also carefully review the forward-looking statements disclaimer in the slide deck that accompanies this conference call and webcast.

There will be an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot